Skip to content

Solventum SOLV Income Statement

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
$2.01B-3.0%$2B-3.7%$2.1B+0.7%$2.16B+3.8%$2.07B+2.7%
$151M+4.9%$157M+6.1%$155M+4.7%$144M-1.4%
$1.1B-1.5%$1.03B-8.2%$1.14B-2.6%$1.18B+3.3%$1.11B-4.9%
54.7%+0.8pp51.4%-2.5pp54.2%-1.8pp54.4%-0.3pp53.8%-4.3pp
$189M-2.1%$175M-12.1%$183M-3.2%$189M-1.6%$193M-1.0%
$827M+7.5%$759M-3.2%$780M+11.3%$772M+10.1%$769M+29.0%
$51M+4.1%$41M+51.9%$34M-39.3%$49M+1,125%
$135M+4.7%$117M-22.0%$121M-9.0%$122M-8.3%$129M-7.2%
-$94M-194%-$35M-294%-$68M-266%-$32M-88.2%
$81M-46.7%$124M-8.8%$1.69B+515%$214M-12.3%$152M-60.1%
4%-3.3pp6.2%-0.3pp80.6%+67.4pp9.9%-1.8pp7.3%-11.6pp
-$62M+40.4%-$51M+52.3%-$89M+16.8%-$103M+9.6%-$104M-167%
-$4M+63.6%-$15M+6.3%-$5M-400%-$8M+76.5%-$11M+15.4%
$16M-57.9%$58M+346%$1.51B+807%$103M+7.3%$38M-88.4%
$3M+103%$0$248M+451%$13M+85.7%-$99M-208%
$13M-90.5%$63M+103%$1.27B+938%$90M+1.1%$137M-42.2%
0.6%-6.0pp3.2%+1.7pp60.4%+54.5pp4.2%-0.1pp6.6%-5.1pp
$0.07-91.0%$0.35+94.4%$7.22+931%$0.510.0%$0.78-43.1%
$0.07-91.1%$0.36+100.0%$7.26+937%$0.52+2.0%$0.79-42.3%
175.5M+0.4%175.3M+0.9%175.4M+0.9%175.2M+1.0%174.8M+1.2%
174.2M+0.3%174.1M+0.5%174.3M+0.5%174.1M+0.5%173.7M+0.6%
$0-100%$0-100%$0-100%$12M
-$62M+40.4%-$51M+52.3%-$89M+16.8%-$103M+9.6%-$104M-167%
$49M0.0%$41M+51.9%$34M-26.1%$49M
$51M+4.1%$41M+51.9%$34M-39.3%$49M+1,125%
$42M-4.5%$35M+59.1%$28M-39.1%$44M+633%
$90M+11.1%$77M-12.5%$78M-9.3%$81M-6.9%
3.6M-12.2%4.3M-14.0%4.4M-26.7%4.1M
-$318M-42.6%$1.15B-$45M-$223M-128%
-$32M-111%$1.29B+331%$358M+254%$294M+94.7%
$226M+2.7%$98M-10.9%$159M+6.0%$220M-8.3%
-$41M+71.5%-$73M-17.7%-$33M-6.5%-$144M-476%
$38M-9.5%$37M0.0%$38M-5.0%$42M-4.5%
-$2M-300%$1M-50.0%$6M$1M
$0.19+107%$0.16-39.0%$0.13+71.2%-$2.62-1,036%
$9M+80.0%$6M+20.0%$6M-40.0%$5M+350%
-$57M
-$21M
$23M+156%$30M-54.5%$51M-25.0%$14M-17.6%$9M-92.2%
$34M+667%$0+100%-$51M$21M-$6M+92.3%
-$151M-41.1%$52M+108%-$107M-133%
-$28M-460%-$7M+78.8%-$33M+52.2%$0+100%-$5M
-$100M-1,567%$24M+116%-$6M
$32M0.0%$5M-84.8%$57M+35.7%$45M+800%$32M-38.5%
$1.3M+18.2%$1.1M+120%$1.1M+267%$1.1M
-$50M+64.0%-$115M-10.6%-$2.69B-1,233%-$110M+72.2%-$139M-130%
-$77M+32.5%$3.77B+4,149%-$110M-89.7%-$114M-11.8%
-$189M-752%$95M-56.6%$76M-55.0%$169M-52.4%$29M-93.4%
-$2M-106%-$9M$31M
0000
3-25.0%4
3
-$48M-134%$38M-76.8%$235M+1,122%$140M
$151M+4.9%$157M+6.1%$155M+4.7%$144M-1.4%
-$12M+14.3%-$44M-340%-$12M-20.0%-$14M
-$63M-141%-$24M-113%$284M+28,300%$154M+279%
-$31M-120%$47M-73.4%$247M+1,444%$156M
$7M+164%$7M+164%-$28M-2,900%-$11M
-$45M-129%$27M-84.8%$268M+2,133%$157M+283%
$15M+1,600%$20M+2,100%-$21M-625%-$1M
-$4M+63.6%-$15M+6.3%-$5M-400%-$8M+76.5%-$11M+15.4%
-$94M-194%-$59M-336%-$35M-294%-$68M-266%-$32M-88.2%
$0-100%$13M$3M
-$7M-240%$6M$7M$0$5M
-$2M-106%$31M-99.6%
$67M$0
$84M-22.9%$63M-50.4%$97M+4.3%$110M+89.7%$109M+6.9%
$14M-6.7%$13M+225%$17M+54.5%$17M+70.0%$15M+66.7%
$46M$0$0$0$0-100%
-$31M-288%$0$68M-$11M-$8M-180%
-$17M-6.3%-$9M+30.8%-$12M+69.2%-$16M
$0-100%$100M0.0%$2.77B+1,285%$100M$100M
$207M$0
$51M+4.1%$37M+48.0%$41M+51.9%$34M-39.3%$49M+1,125%
$31M+288%$8M
922.6K0
$67M
$81M-46.7%$124M-8.8%$1.69B+515%$214M-12.3%$152M-60.1%
$216M-23.1%$241M-15.7%$1.81B+344%$336M-10.9%$281M-46.0%
$216M-23.1%$241M-15.7%$1.81B+344%$336M-10.9%$281M-46.0%
10.8%-2.8pp12.1%-1.7pp86.4%+66.8pp15.5%-2.6pp13.6%-12.2pp
$81M-46.7%$124M-8.8%$1.69B+515%$214M-12.3%$152M-60.1%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What is Solventum's revenue?
Solventum (SOLV) generated $8.3B in revenue over the trailing twelve months, down 0.5% year over year.
Is Solventum profitable?
Solventum reported $1.4B in net income over the trailing twelve months, a 17.3% net margin.
What are Solventum's profit margins?
Gross margin is 53.7% and operating margin is 25.5%, with a 17.3% net margin.
What is Solventum's earnings per share?
Solventum's diluted EPS over the trailing twelve months is $8.15.
Where does Solventum's income statement data come from?
Every line is extracted from Solventum's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.